Oncocyte IMDX
Oncocyte: signs a material agreement, completes an acquisition or sale of assets and makes a Regulation FD disclosure
- Form
- 8-K
- Filed
- Period
- Importance
- Major
- Accession
- 0001493152-23-005890
- Document
- 8-K
- Exhibit 99.1
- Press release
- Signs a material agreement (1.01)
- Completes an acquisition or sale of assets (2.01)
- Makes a Regulation FD disclosure (7.01)
Not explained yet; the original is on EDGAR.
Similar companies
Companies of similar size in SIC 2835 and related industry codes: the same peer list as the financial tables.
- Rein Therapeutics RNTX public float $32M, Jun 30, 2025
- Yarrow Bioscience VYNE public float $32M, Jun 30, 2025
- Kezar Life Sciences KZR public float $33M, Jun 30, 2025
- Scorpius Holdings SCPX
- Provectus Biopharmaceuticals PVCT public float $31M, Jun 30, 2025
